The electroencephalogram (EEG) and clinical measures of opioid potency: defining the EEG-clinical potency relationship (‘fingerprint’) with application to remifentanil

Author： TD E.   KT M.   DJ H.   DR S.   SL S.  

Publisher： Adis International

ISSN： 1364-9027

Source： International Journal of Pharmaceutical Medicine, Vol.15, Iss.1, 2001-02, pp. : 11-19

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Remifentanil, a different opioid: potential clinical applications and safety aspects

By Stroumpos Charalampos   Manolaraki Maria   Paspatis Gregorios A  

Expert Opinion on Drug Safety, Vol. 9, Iss. 2, 2010-03 ,pp. : 355-364

Informa Healthcare

Access to resources Recommend Favorite

The effects of trazodone on sleep: a clinical and EEG study in patients with major depression

By Arriaga F.   Paiva T.   Cavaglia F.   Pinheira G.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 309-310

Elsevier

Access to resources Recommend Favorite

Quantitative Electroencephalogram (EEG) in Insomnia: A New Window on Pathophysiological Mechanisms

By  

Current Pharmaceutical Design, Vol. 14, Iss. 32, 2008-11 ,pp. : 3446-3455

Bentham Science Publishers

Access to resources Recommend Favorite

Remifentanil Update: Clinical Science and Utility

By Richard Beers   Enrico Camporesi  

CNS Drugs, Vol. 18, Iss. 15, 2004-01 ,pp. : 1085-1104

Adis International

Access to resources Recommend Favorite

Onset–potency relationship of nondepolarizing muscle relaxants: a reexamination using simulations

By Bhatt S.B.   Amann A.   Nigrovic V.  

Canadian Journal of Physiology and Pharmacology, Vol. 85, Iss. 8, 2007-08 ,pp. : 774-782

NRC Research Press

Access to resources Recommend Favorite